Descovy 200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F21DM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,280
Award facts
- Contract value 100% obligated
- $10,280.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,280.36 to AmerSourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on January 22, 2026, with an ultimate completion date of January 23, 2026. This competitively awarded, firm fixed-price contract involves no set-aside designation and is performed at AmerSourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract is issued under AmerSourceBergen's parent company, Cencora, Inc., which holds a substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031, serving as the primary vehicle for delivering pharmaceutical products and medical supplies to military healthcare programs globally.
DESCOVY is an antiretroviral medication used for HIV treatment and prevention, representing the type of critical pharmaceutical commodity that the DLA Medical Supply Chain procures to support military healthcare operations and beneficiaries worldwide. AmerSourceBergen's delivery of this specialized medication demonstrates the company's established role as a key pharmaceutical vendor within the federal procurement system, leveraging its expansive IDC with DLA to fulfill time-sensitive medical supply requirements across multiple therapeutic domains for the Department of Defense and related federal health systems.
Quick answers
Who was awarded contract SPE2DR26F21DM?
SPE2DR26F21DM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26F21DM worth?
The government has obligated $10,280 on SPE2DR26F21DM.
Is contract SPE2DR26F21DM an order under another contract?
Yes. SPE2DR26F21DM is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F21DM competed?
The extent of competition for SPE2DR26F21DM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award